NCT00005988View on ClinicalTrials.gov

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

June 16, 2001

Study Completion Date

March 8, 2002

Conditions
Graft Versus Host DiseaseLeukemiaLymphomaMyelodysplastic SyndromesMyeloma
Interventions
DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

methylprednisolone

PROCEDURE

in vitro-treated bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (2)

55455

University of Minnesota Cancer Center, Minneapolis

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00005988 - Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy | Biotech Hunter | Biotech Hunter